| 02.05 23:39 | dpa-AFX: Amgen steigert Umsatz kräftig - Abnehmpille sorgt beim Aktienkurs für Höhenflüge |
| 02.05 23:39 | Amgen steigert Umsatz kräftig - Abnehmpille sorgt beim Aktienkurs für Höhenflüge |
| 02.05 23:34 | dpa-AFX: Amgen steigert Umsatz kräftig - Abnehmpille sorgt beim Aktienkurs für Höhenflüge |
| 02.05 23:08 | dpa-AFX: *AMGEN DREHEN NACHBÖRSLICH INS PLUS - ZULETZT +11% |
| 02.05 22:11 | dpa-AFX: *AMGEN NACHBÖRSLICH -1% - QUARTALSZAHLEN UNSPEKTAKULÄR |
| 02.05 22:05 | dpa-AFX: Amgen Inc. Q1 Earnings Summary |
| 02.05 22:03 | dpa-AFX: *AMGEN Q1 NET LOSS $113 MLN VS. PROFIT $2.84 BLN PRIOR YEAR |
| 02.05 22:03 | dpa-AFX: *AMGEN Q1 LOSS/SHARE $0.21 VS. PROFIT $5.28 YEAR AGO |
| 02.05 22:03 | dpa-AFX: *AMGEN Q1 REVENUES $7.45 BLN VS. $6.11 BLN LAST YEAR |
| 02.05 12:03 | dpa-AFX: Amgen Q1 24 Earnings Conference Call At 4:30 PM ET |
| 26.04 15:33 | dpa-AFX: Amgen Announces Imminent Submission Of MAA To European Medicines Agency For Teprotumumab |
| 26.04 15:02 | dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT |
| 06.03 22:10 | dpa-AFX: *AMGEN DECLARES QUARTERLY DIVIDEND OF $2.25/SHARE, PAYABLE JUNE 7/ RECORD MAY 17 |
| 06.03 22:02 | dpa-AFX: *AMGEN INC. (AMGN) DECLARES $ 2.25 DIVIDEND FOR Q2 24, RECORD DATE 5/17/2024 |
| 05.03 14:14 | dpa-AFX: Amgen To Present At TD Cowen Health Care Conference; Webcast At 9:10 AM ET |
| 26.02 15:27 | dpa-AFX: Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs |
| 26.02 15:05 | dpa-AFX: *AMGEN SAYS NEARLY 300,000-SQUARE-FOOT FACILITY IN CENTRAL OHIO WILL EMPLOY 400 FULL-TIME STAFF |
| 26.02 15:03 | dpa-AFX: *AMGEN ANNOUNCES OPENING OF MANUFACTURING SITE IN CENTRAL OHIO |
| 14.02 16:46 | dpa-AFX: *LBBW HEBT ZIEL FÜR AMGEN AUF 290 (270) USD - 'HALTEN' |
| 14.02 16:46 | dpa-AFX: *LBBW RAISES AMGEN PRICE TARGET TO 290 (270) USD - 'HOLD' |
|
|
